ABA Pandemic Update American Bankers Association

Paul Benda returns with the ABA Pandemic Update after a three week break to account for a spring break family trip to Greece returns. Benda reports they made the trip COVID-free. On this episode, he talks about a recent rise in cases, new BA.2 variants, fourth doses and improved booster shots, the dropping of mask mandates, and what the next few weeks and months may look like.

In the latest episode of the biweekly Pandemic Update podcast, ABA SVP Paul Benda discusses cases plateauing nationally but rising in 15 states, second booster shots and when to get them, virus mutations, some good news on recovered immunity and things to look for in the future.

In the latest episode of the biweekly Pandemic Update podcast, ABA SVP Paul Benda discusses the continued drop of COVID-19 cases in the U.S., the rise in cases in Europe, a new “scariant” Deltacron, vaccines and treatments for children and the news from Asia. Benda also talks about if the country has reached the point where COVID-19 is less deadly than the flu.

In the latest episode of the biweekly Pandemic Update podcast, ABA SVP Paul Benda discusses the continued good news around declining case counts and updated masking guidance from the Centers for Disease Control and Prevention. Benda also talks about Novavax’s vaccine, a study from New York on the efficacy of vaccines for children ages 5 to 11, Omicron reinfection protection and multiple new reports on the origins of COVID-19.

In the latest episode of the weekly Pandemic Update podcast, ABA SVP Paul Benda discusses further downward trends of COVID-19 cases, whether BA.2 or the stealth variant is likely to change those trends, omicron hospitalization data for children, good and bad news on the value of recovered immunity, third dose booster waning, the value of fourth doses, and the future of the podcast.

In the latest episode of the weekly Pandemic Update podcast, ABA SVP Paul Benda discusses continuing good news on COVID-19 case counts, omicron variant BA.2 in the U.S., trends in removing restrictions and a potential framework to guide that removal, omicron specific booster data, and what Anthony Fauci, President Biden’s top medical adviser for the coronavirus says about the future.